Development of Biologics:
Our Experience – Your Track to Success

Contact us

Meso Scale Discovery (MSD)
The Multiplexing platform

Read more

Gyrolab
The nanoliter-scale immunoassay platform

Read more

Advanced detection modes
Alpha Technology - TR-FRET - TRF

Read more

BD FACSLyric and assay portability:
the key to efficient method transfer and high data reproducibility

Read more

Our Quality Standards

Read more

In touch with science – to success in market!

Immunoassay platforms

Meso Scale

IBR Inc. offers the MSD ECL immunoassay platform. The SECTOR S 600 instrument is a powerful tool whenever an assay demands multiplexing with high sensitivity, even in complex matrices, such as serum or plasma.

Read more
Immunoassay platforms

Gyrolab

With Gyrolab™ xPlore IBR Inc. offers an immunoassay platform for high throughput and sample requirement down to nanoliter-scale. The system provides automated sample and reagent dispensing and is capable of processing up to 112 data points in 1 hour.

Read more
Advanced detection modes

Alpha – TR-FRET – TRF

Complementing the classical detection modes, the advanced Time-Resolved Fluorescence (TRF) and proximity detection modes like TR-FRET and Alpha widen up the ways to detect biomolecular interactions and functions.

Read more
HiTech platforms

BD FACSLyric

Our BD FACSLyric has been designed to achieve a high level of standardization. The assay settings can be easily transferred to another cytometer, thereby substantially reducing instrument to instrument variation.

Read more
Quality at IBR Inc.

Our standards

The IBR Inc. laboratories are GLP compliant since 2001 and directed by our in-house Quality Assurance Manager. The quality standard of Good Clinical Practice has been introduced at IBR Inc. in 2012.

Read more
Services

Cell-based assays

IBR Inc. has a longstanding experience in cell-based assays including primary cells, transformed cell lines, reporter-gene as well as 3D cell systems.

Read more

Our focus

IBR Inc., Institute for Biopharmaceutical Research is a Swiss GxP-compliant contract research organization founded in 1998. We are a first-in-class site in the field of bioanalytical services for therapeutic antibodies, biologics, biosimilars, antibody-drug conjugates and vaccines covering the bioanalytical needs from pre-clinical to clinical development.

We are experienced in driving studies on cytokines, chemokines and other biomarkers, drug/target binding and immunogenicity. Furthermore, we perform cell-based assays with a broad variety of readouts. Our team has vast experience with primary cells, transformed cell lines, transfected cells, reporter-gene cell systems and 3D cell-based assays.

IBR Inc. moves on with rapid and constantly growing advances in technology and offers advanced platforms including Alpha Technology, Time Resolved Fluorescence (TRF), MSD® ECL, Gyrolab, state-of-the-art Flow Cytometry / Cytometric Bead Array and real time PCR, beside a broad variety of classical techniques.

With IBR Inc. your studies are supported from assay development to assay validation and sample measurement. We have capability to perform studies in compliance with regulatory guidelines for GLP and GCP quality standards, following the principles of ICH Q2 (R1), USP 1032, 1033 and 1034. Our study reports are compliant with eCTD requirements.